X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (60) 60
male (50) 50
female (45) 45
index medicus (42) 42
animals (31) 31
middle aged (27) 27
adult (23) 23
rats (19) 19
aged (18) 18
neurosciences (16) 16
analysis (12) 12
children (11) 11
rats, wistar (11) 11
biochemistry & molecular biology (10) 10
child (10) 10
gene expression (10) 10
zinc (10) 10
brain (9) 9
mice (9) 9
pregnancy (9) 9
risk factors (9) 9
treatment outcome (9) 9
adolescent (8) 8
cardiac & cardiovascular systems (8) 8
cells, cultured (8) 8
child, preschool (8) 8
clinical neurology (8) 8
depression (8) 8
medicine (8) 8
pediatrics (8) 8
echocardiography (7) 7
infant (7) 7
oncology (7) 7
poland - epidemiology (7) 7
studies (7) 7
time factors (7) 7
apoptosis (6) 6
astrocytes (6) 6
biology (6) 6
central-nervous-system (6) 6
diet (6) 6
follow-up studies (6) 6
ischemia (6) 6
nutrition (6) 6
pharmacology & pharmacy (6) 6
poland (6) 6
rodents (6) 6
serum (6) 6
social sciences (6) 6
tacrolimus - pharmacology (6) 6
biotechnology (5) 5
cancer (5) 5
care and treatment (5) 5
disease models, animal (5) 5
electrocardiography (5) 5
endocrinology & metabolism (5) 5
expression (5) 5
hematology (5) 5
immunosuppressive agents - pharmacology (5) 5
inflammation (5) 5
magnetic resonance imaging (5) 5
microglia (5) 5
neuroprotective agents - pharmacology (5) 5
prognosis (5) 5
psychiatry (5) 5
psychology (5) 5
public, environmental & occupational health (5) 5
retrospective studies (5) 5
risk (5) 5
stroke (5) 5
adolescents (4) 4
age factors (4) 4
antidepressants (4) 4
antioxidants (4) 4
association (4) 4
astrocytes - drug effects (4) 4
astrocytes - metabolism (4) 4
biochemistry, general (4) 4
cardiac patients (4) 4
cerebral-artery occlusion (4) 4
chemistry (4) 4
copper (4) 4
disease (4) 4
drugs (4) 4
electromagnetic radiation (4) 4
fk506 (4) 4
gene-expression (4) 4
genes (4) 4
health aspects (4) 4
imipramine (4) 4
immunology (4) 4
infant, newborn (4) 4
infarction, middle cerebral artery - physiopathology (4) 4
life sciences (4) 4
lipid peroxidation (4) 4
magnesium (4) 4
major depression (4) 4
medical research (4) 4
medicine, research & experimental (4) 4
mortality (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Pathology, ISSN 0022-3417, 07/2013, Volume 230, Issue 3, pp. 310 - 321
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 12/2014, Volume 53, Issue 49, pp. 13600 - 13604
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 05/2010, Volume 113, Issue 4, pp. 904 - 918
P>Although, astrocytes are more resistant than neurons to ischemic injury, astrocyte death has been demonstrated in animal models of brain ischemia. Astrocytes... 
Extracellular signal-regulated kinases 1/2 | Ischemia | Astrocytes | FK506 | Glutamate transporters | Glutamate toxicity | Apoptosis | glutamate toxicity | NEURONAL CELL-LINE | SIGNALING PATHWAYS | BRAIN-INJURY | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOCAL CEREBRAL-ISCHEMIA | apoptosis | FOREBRAIN ISCHEMIA | NEUROSCIENCES | ischemia | IN-VITRO | extracellular signal-regulated kinases 1 | INHIBITION | MEK1 PROTEIN-KINASE | CULTURED ASTROCYTES | astrocytes | glutamate transporters | MOLECULAR-MECHANISMS | Infarction, Middle Cerebral Artery - physiopathology | MAP Kinase Signaling System - physiology | Nitriles - pharmacology | Rats, Wistar | Apoptosis - drug effects | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Astrocytes - pathology | Male | Infarction, Middle Cerebral Artery - metabolism | Amino Acid Transport System X-AG - metabolism | Neuroprotective Agents - pharmacology | Tacrolimus - pharmacology | Infarction, Middle Cerebral Artery - drug therapy | Immunosuppressive Agents - pharmacology | Hypoxia-Ischemia, Brain - metabolism | Animals, Newborn | Astrocytes - drug effects | MAP Kinase Kinase 1 - antagonists & inhibitors | Butadienes - pharmacology | Cells, Cultured | Enzyme Inhibitors - pharmacology | Hypoxia-Ischemia, Brain - drug therapy | Rats | MAP Kinase Kinase 1 - metabolism | Enzyme Activation - drug effects | Amino Acid Transport System X-AG - antagonists & inhibitors | Animals | MAP Kinase Signaling System - drug effects | Mitogen-Activated Protein Kinase 3 - metabolism | Glutamic Acid - metabolism | Apoptosis - physiology | Glutamic Acid - toxicity | Enzyme Activation - physiology | Astrocytes - metabolism | Hypoxia-Ischemia, Brain - physiopathology | Brain | Phosphatases | Neurons | Analysis | Amino acids | Gene expression | Glutamate | Phosphotransferases | Neurology | Cell culture | Biochemistry | Kinases
Journal Article
Journal Article
Glia, ISSN 0894-1491, 01/2005, Volume 49, Issue 1, pp. 36 - 51
Immunosuppressant FK506 is neuroprotective in experimental models of cerebral ischemia, but the molecular mechanisms underlying this neuroprotection remain... 
immunosuppressant | interleukin‐1 | pro‐inflammatory cytokines | astrocytes | microglia | neuroprotection | Pro-inflammatory cytokines | Immunosuppressant | Neuroprotection | Interleukin-1 | Astrocytes | Microglia | IMMUNOSUPPRESSANT FK506 | GLIOMA-CELLS | interleukin-1 | TRANSIENT GLOBAL-ISCHEMIA | FOREBRAIN ISCHEMIA | HIPPOCAMPAL-NEURONS | NEUROSCIENCES | ISCHEMIA-REPERFUSION INJURY | MITOCHONDRIAL PERMEABILITY TRANSITION | CYCLOSPORINE-A | pro-inflammatory cytokines | CEREBRAL-ARTERY OCCLUSION | AP-1 TRANSCRIPTION FACTOR | Cerebral Infarction - immunology | Neuroprotective Agents - therapeutic use | Cerebral Infarction - drug therapy | Infarction, Middle Cerebral Artery - physiopathology | Interleukin-1 - genetics | Rats, Wistar | Immunosuppressive Agents - therapeutic use | Tumor Necrosis Factor-alpha - genetics | Reperfusion Injury - drug therapy | Male | Infarction, Middle Cerebral Artery - immunology | Lipopolysaccharides - antagonists & inhibitors | RNA, Messenger - metabolism | Neuroglia - drug effects | Microglia - immunology | Neuroprotective Agents - pharmacology | Astrocytes - immunology | Tacrolimus - pharmacology | Infarction, Middle Cerebral Artery - drug therapy | Gliosis - immunology | Cytokines - genetics | Gliosis - prevention & control | Immunosuppressive Agents - pharmacology | Cerebral Infarction - pathology | Disease Models, Animal | Ischemic Attack, Transient - physiopathology | RNA, Messenger - drug effects | Animals, Newborn | Astrocytes - drug effects | Ischemic Attack, Transient - drug therapy | Interleukin-6 - genetics | Microglia - drug effects | Brain - physiopathology | Cells, Cultured | Rats | Down-Regulation - drug effects | Brain - drug effects | Animals | Down-Regulation - immunology | Reperfusion Injury - immunology | Reperfusion Injury - physiopathology | Neuroglia - metabolism | Gliosis - drug therapy | Ischemic Attack, Transient - immunology | Brain - immunology
Journal Article
The Journal of Supercritical Fluids, ISSN 0896-8446, 07/2015, Volume 102, pp. 92 - 97
One of the research directions in the material engineering is the search for porous bodies with fine structure. Biotechnologies implementing natural products... 
Supercritical carbon dioxide | Adsorption | Microstructure | Plant structure | Drying | ENGINEERING, CHEMICAL | CHEMISTRY, PHYSICAL | CARBON-DIOXIDE
Journal Article
Journal Article
Journal Article
Cell Stem Cell, ISSN 1934-5909, 2010, Volume 6, Issue 6, pp. 578 - 590
After central nervous system (CNS) demyelination—such as occurs during multiple sclerosis—there is often spontaneous regeneration of myelin sheaths, mainly by... 
STEMCELL | PDGF ALPHA-RECEPTOR | MULTIPLE-SCLEROSIS LESIONS | NEURAL PROGENITOR | REMYELINATION OCCURS | EMBRYONIC SPINAL-CORD | CENTRAL-NERVOUS-SYSTEM | INTRASPINAL INJECTION | RAT-BRAIN | NG2 PROTEOGLYCAN | PRECURSOR CELLS | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Oligodendroglia - metabolism | Demyelinating Diseases - genetics | Astrocytes - pathology | Central Nervous System - pathology | Demyelinating Diseases - metabolism | Central Nervous System - surgery | Lysophosphatidylcholines - administration & dosage | Multiple Sclerosis - physiopathology | Basic Helix-Loop-Helix Transcription Factors - biosynthesis | Nerve Tissue Proteins - biosynthesis | Female | Demyelinating Diseases - chemically induced | Adult Stem Cells - pathology | Demyelinating Diseases - pathology | Receptor, Fibroblast Growth Factor, Type 3 - biosynthesis | Disease Models, Animal | Multiple Sclerosis - metabolism | Receptor, Platelet-Derived Growth Factor alpha - biosynthesis | Demyelinating Diseases - physiopathology | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Basic Helix-Loop-Helix Transcription Factors - genetics | Cells, Cultured | Mice, Transgenic | Multiple Sclerosis - genetics | Schwann Cells - pathology | Oligodendrocyte Transcription Factor 2 | Schwann Cells - metabolism | Nerve Regeneration | Nerve Tissue Proteins - genetics | Oligodendroglia - pathology | Adult Stem Cells - metabolism | Animals | Microscopy | Receptor, Platelet-Derived Growth Factor alpha - genetics | Central Nervous System - drug effects | Multiple Sclerosis - pathology | Mice | Integrases - genetics | Astrocytes - metabolism
Journal Article